[1]
A. Bhattacharjee, M. C. Gupta, and S. Agrawal, “Adverse drug reaction monitoring of newer oral anti diabetic drugs a pharmacovigilance perspective”, Int J of Pharmc Res, vol. 6, no. 4, pp. 142–151, Apr. 2016, doi: 10.7439/ijpr.v6i4.3068.